CLADE THERAPEUTICS, INC.

Profile

Company Names

CLADE THERAPEUTICS, INC.

Addresses

1 KENDALL SQUARE, SUITE B200, CAMBRIDGE, MA 02139

Phone Numbers

415-886-7710

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$45,934,093.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-12-17 
$42,000.00 
$66,000.00 
$24,000.00 
Equity 
1
2021-08-11 
$45,892,093.00 
$87,142,085.00 
$41,249,992.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHAD 
A. 
COWAN 
EXECUTIVE OFFICER, DIRECTOR
CLADE THERAPEUTICS, INC.
JIM 
 
GLASHEEN 
EXECUTIVE OFFICER, DIRECTOR
TRANSCEND MEDICAL INC   |  REVANCE THERAPEUTICS, INC.   |  INCLINE THERAPEUTICS, INC.   |  ELCELYX THERAPEUTICS, INC.   |  FORSIGHT VISION5, INC.   |  CLADE THERAPEUTICS, INC.
MARTIN 
 
MURPHY 
DIRECTOR
ALDAGEN INC   |  JENNEREX, INC.   |  INTEGRATED ENDOSCOPY, INC.   |  CAMBRIDGE EPIGENETIX LTD   |  CLADE THERAPEUTICS, INC.   |  AUTOLUS THERAPEUTICS PLC
DANIEL 
 
VASELLA 
DIRECTOR
MPHARMA DATA, INC   |  ECLIPSE BIOINNOVATIONS, INC.   |  CLADE THERAPEUTICS, INC.
LEANDRO 
 
VETCHER 
EXECUTIVE OFFICER
GREEN PACIFIC BIOLOGICALS, INC.   |  CLADE THERAPEUTICS, INC.
NEIL 
 
WHITE 
DIRECTOR
CENTERCODE, INC.   |  CLADE THERAPEUTICS, INC.   |  THEONYS, INC.   |  PENTA PARENT HOLDINGS, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-01-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-17 
2021-11-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#